ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
9.65
-0.25 (-2.53%)
At close: Jun 18, 2026, 4:00 PM EDT
10.00
+0.35 (3.63%)
After-hours: Jun 18, 2026, 6:08 PM EDT
ARS Pharmaceuticals Employees
As of March 31, 2026, ARS Pharmaceuticals had 159 total employees, including 154 full-time and 5 part-time employees. The number of employees decreased by 4 or -2.45% since the number was last reported on December 31, 2025.
Employees
159
Change
-4
Growth
-2.45%
Revenue / Employee
$622,553
Profits / Employee
-$1,245,132
Market Cap
958.28M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 159 | -4 | -2.45% | 154 | 5 |
| Dec 31, 2025 | 163 | 3 | 1.88% | 158 | 5 |
| Dec 31, 2024 | 160 | 134 | 515.38% | 155 | 5 |
| Dec 31, 2023 | 26 | 6 | 30.00% | 24 | 2 |
| Dec 31, 2022 | 20 | 11 | 122.22% | 17 | 3 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 409 |
| Pharming Group | 407 |
| Xencor | 260 |
| DBV Technologies | 161 |
| Sana Biotechnology | 142 |
| ORIC Pharmaceuticals | 104 |
| Lexicon Pharmaceuticals | 81 |
| Jade Biosciences | 55 |
SPRY News
- 21 days ago - ARS Pharmaceuticals price target raised to $30 from $12 at Cantor Fitzgerald - TheFly
- 4 weeks ago - ARS Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - ARS Pharmaceuticals Earnings release: Q1 2026 - Filings
- 4 weeks ago - ARS Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 4 weeks ago - ARS Pharmaceuticals reports Q1 EPS (61c), consensus (54c) - TheFly
- 4 weeks ago - ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update - GlobeNewsWire
- 5 weeks ago - ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President - GlobeNewsWire
- 6 weeks ago - ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results - GlobeNewsWire